A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
Condition(s):Uterine Cervical DysplasiaLast Updated:May 29, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Uterine Cervical DysplasiaLast Updated:May 29, 2013Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:December 19, 2023Active, not recruiting
Condition(s):Cervix Lesion; Cervical CancerLast Updated:October 12, 2023Recruiting
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3Last Updated:March 29, 2023Active, not recruiting
Condition(s):CIN3; CIN2; Cervical CancerLast Updated:March 14, 2023Active, not recruiting
Condition(s):Human Papilloma Virus Infection; Cervical Intraepithelial Neoplasia Grade 2/3Last Updated:October 17, 2016Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:August 16, 2018Unknown status
Condition(s):Cervical Dysplasia; Cervical High Grade Squamous Intraepithelial Lesion; HSILLast Updated:July 27, 2023Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:September 22, 2014Completed
Condition(s):HIV Infections; HPV Infection; CIN 2/3Last Updated:March 22, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.